Keyphrases
Placebo
100%
Transarterial Chemoembolization
100%
Liver Metastasis
100%
Transarterial Embolization
100%
Intervention Group
33%
Confidence Interval
25%
Risk Ratio
25%
Risk of Bias
25%
Group Risk
25%
High Risk
16%
Beneficial Effects
16%
Health-related Quality of Life
16%
Therapeutic Intervention
16%
Colorectal Liver Metastases
16%
Harmful Effects
16%
Median Survival
16%
Liver
16%
Tumor Response
16%
Cochrane
16%
Hepatic Artery
16%
Time to Progression
16%
Primary Liver Cancer
16%
Metastasis Tumor
16%
Response Measures
16%
Tumor
8%
Randomized Clinical Trial
8%
Clinical Trials
8%
Chemotherapy
8%
Adverse Events
8%
Randomized Trial
8%
Deep Vein Thrombosis
8%
Standards of Conduct
8%
Intervention Studies
8%
Between-group
8%
Resection
8%
Cancer Research
8%
MEDLINE
8%
Embase
8%
Blood Supply
8%
Malignant Tumor
8%
R0 Resection
8%
Colorectal Carcinoma
8%
Wound Infection
8%
Necrosis
8%
Vomiting
8%
Nausea
8%
Local Recurrence
8%
Participant Characteristics
8%
5-fluorouracil (5-FU)
8%
Hematoma
8%
Delivery System
8%
Degradable
8%
U.S. Food
8%
Tumor Metastasis
8%
Review Authors
8%
Without Chemotherapy
8%
Nonprofit Organizations
8%
Reporting Standards
8%
Primary Cancer
8%
First-line Chemotherapy
8%
Large Trials
8%
Administration Database
8%
Ongoing Trials
8%
Hepatic Arterial Infusion Chemotherapy
8%
Liver Tumor
8%
Hepatobiliary
8%
Hepatic Tumor
8%
Hepatic Artery Embolization
8%
Trial Method
8%
Chemotherapy Alone
8%
Radical Surgical Treatment
8%
Methodological Procedures
8%
Certainty of Evidence
8%
Long-term Survival Rate
8%
Unresectable Liver Metastases
8%
Port-a-cath
8%
Post-embolization Syndrome
8%
Degradable Starch Microspheres
8%
Resectable Liver Metastases
8%
Extracted Data
8%
Inconclusive Result
8%
Synchronous Metastases
8%
Group Allocation
8%
Puncture Site
8%
Follow Current
8%
Short-term Symptoms
8%
INIS
liver
100%
interventions
100%
metastases
100%
vascular diseases
100%
tumors
30%
risks
26%
range
26%
chemotherapy
21%
people
21%
cancer
17%
arteries
17%
mortality
17%
control
17%
comparative evaluations
13%
data
8%
clinical trials
8%
quality of life
8%
failures
8%
microspheres
8%
surgery
4%
information
4%
drugs
4%
females
4%
symptoms
4%
blood
4%
males
4%
veins
4%
side effects
4%
allocations
4%
reviews
4%
design
4%
delivery
4%
vomiting
4%
thrombosis
4%
carcinomas
4%
grants
4%
supply
4%
profits
4%
food and drug administration
4%
ports
4%
necrosis
4%
hematomas
4%
infusion
4%
wounds
4%
nausea
4%
uracils
4%
starch
4%
Medicine and Dentistry
Placebo
100%
Liver Metastasis
100%
Embolization
100%
Transcatheter Arterial Chemoembolization
100%
Common Hepatic Artery
30%
High Risk Population
23%
Quality of Life
15%
Liver Tumor
15%
Colorectal Carcinoma
15%
Parenchyma
7%
Neoplasm
7%
Adverse Event
7%
Malignant Neoplasm
7%
Side Effect
7%
Long Term Survival
7%
Recurrent Disease
7%
Clinical Trial
7%
Cancer Research
7%
Antiinfective Agent
7%
Wound Infection
7%
Intervention Study
7%
Deep Vein Thrombosis
7%
Randomized Clinical Trial
7%
Vascularity
7%
Necrosis
7%
Survival Rate
7%
Metastatic Carcinoma
7%
Primary Tumor
7%
Fluorouracil
7%
Liver Cancer
7%
Symptomatic Treatment
7%
Nausea
7%
Intraarterial Drug Administration
7%
Colorectal Liver Metastasis
7%
Hematoma
7%
Puncture
7%
Arterial Embolization
7%
First-Line Chemotherapy
7%
Starch Microsphere
7%
Microsphere
7%
Nursing and Health Professions
Placebo
100%
Artificial Embolization
100%
Liver Metastasis
100%
Chemoembolization
100%
Confidence Interval
23%
High Risk Population
23%
Quality of Life
15%
Liver Tumor
15%
Colorectal Carcinoma
15%
Neoplasm
7%
Adverse Event
7%
Antiinfective Agent
7%
Wound Infection
7%
Side Effect
7%
Deep Vein Thrombosis
7%
Malignant Neoplasm
7%
Embase
7%
Nausea
7%
Syndrome
7%
Recurrent Disease
7%
Survival Rate
7%
Long Term Survival
7%
Palliative Therapy
7%
Hematoma
7%
Primary Tumor
7%
Non Profit Organization
7%
Puncture
7%
Liver Cancer
7%
Cancer Research
7%
Food and Drug Administration
7%
Necrosis
7%
Microsphere
7%
Fluorouracil
7%
Intraarterial Drug Administration
7%
Colorectal Liver Metastasis
7%
Arterial Embolization
7%
Starch Microsphere
7%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Liver Metastasis
100%
Chemotherapy
30%
Malignant Neoplasm
15%
Liver Tumor
15%
Colorectal Carcinoma
15%
Neoplasm
7%
Adverse Event
7%
Syndrome
7%
Deep Vein Thrombosis
7%
Side Effect
7%
Clinical Trial
7%
Recurrent Disease
7%
Wound Infection
7%
Antiinfective Agent
7%
Survival Rate
7%
Intervention Study
7%
Nausea
7%
Primary Tumor
7%
Fluorouracil
7%
Necrosis
7%
Liver Cancer
7%
Randomized Clinical Trial
7%
Colorectal Liver Metastasis
7%
Hematoma
7%
Long Term Survival
7%
First-Line Chemotherapy
7%
Starch Microsphere
7%
Microsphere
7%